RxDoctor Payments Data

Ivan Maillard, MD

Hematology · Philadelphia, PANPI 1568403269

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,980 of the $5,799 with a category attached, or 85.9%. Gilead accounts for 72.9% of it on its own, with 2 other manufacturers making up the rest. 2024 is the largest year on record at $4,228, more than ten times the $62 reported in 2019.

$5,799in general payments, 2019–2025

Across 6 payments — averaging $966.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$4K
  • Genentech USA, Inc.$1K
  • Regeneron$150
$266,972in research payments, 2019–2025

Across 5 payments — averaging $53,394 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$194K
  • Genentech, Inc.$73K

What the payments were for

  • Consulting fees$4,98086%
  • Travel & lodging$5379%
  • Food & beverage$2815%

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead3$4,228
Genentech USA, Inc.1$1,420
Regeneron2$150

How this compares

$5,799 in reported general payments places this provider in the 70th percentile of 64 hematology providers in Pennsylvania.

See all hematology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$14,658
Medicare patients
28
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →